CORRIGENDUM: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease (Nature Reviews Drug Discovery, (2017), 16, (755–772), 10.1038/nrd.2017.170)

Ana L. Mora; Mauricio Rojas; Annie Pardo; Moises Selman

ArticleOPEN ACCESS

CORRIGENDUM: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease (Nature Reviews Drug Discovery, (2017), 16, (755–772), 10.1038/nrd.2017.170)

Nature Reviews Drug Discovery

DOI: 10.1038/NRD.2017.225

94Citations

22Readers

Get full text

Abstract

In the original version, navitoclax was incorrectly referred to as an apoptosis inhibitor in Figure 3. The error has been corrected online.

Cite

CITATION STYLE

APA

Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017). CORRIGENDUM: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease (Nature Reviews Drug Discovery, (2017), 16, (755–772), 10.1038/nrd.2017.170). Nature Reviews Drug Discovery. Nature Research. https://doi.org/10.1038/NRD.2017.225

CORRIGENDUM: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease (Nature Reviews Drug Discovery, (2017), 16, (755–772), 10.1038/nrd.2017.170)

Abstract

Cite

Register to see more suggestions